Firefly Neuroscience (AIFF) Accounts Payables (2010 - 2026)

Firefly Neuroscience's Accounts Payables history runs 16 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 17.56% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 17.56% YoY), while the FY2025 annual figure was $1.3 million, down 25.83% from the prior year.
• Accounts Payables was $1.3 million for Q1 2026 at Firefly Neuroscience, down from $1.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.8 million in Q4 2024 to a low of $227560.0 in Q3 2022.
• Historically, Accounts Payables has averaged $993201.2 across 5 years, with a median of $839711.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables plunged 75.44% in 2022, then soared 188.25% in 2024.
• A 5-year view of Accounts Payables shows it stood at $573789.0 in 2022, then advanced by 9.8% to $630000.0 in 2023, then jumped by 188.25% to $1.8 million in 2024, then fell by 25.83% to $1.3 million in 2025, then fell by 1.34% to $1.3 million in 2026.
• The last three Accounts Payables figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.